Trials / Completed
CompletedNCT05320302
A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants
Interventional, Open-Label, Positron Emission Tomography (PET) Study With [11C]-Lu AF88370 Investigating Blood-Brain Barrier Penetration of Lu AF88370 in Healthy Men
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main goals of the study are to assess uptake and distribution of Lu AF88370 in the brain when given at tracer levels (microdose) in healthy young men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [11C]-Lu AF88370 | PET ligand in a single intravenous bolus injection |
Timeline
- Start date
- 2022-03-31
- Primary completion
- 2022-06-15
- Completion
- 2022-06-20
- First posted
- 2022-04-11
- Last updated
- 2022-07-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05320302. Inclusion in this directory is not an endorsement.